In summary, through dual IGF1/R and MEK inhibition, we have identified a group of genes that appear to contribute to impaired apoptotic responses to DNA damage and, when targeted, can sensitize ALL cells to chemotherapy agents. This evidence concerns the gene IGF1 and acute lymphoblastic leukemia.